RedDress ships wound care systems to Ukraine
By HME News Staff
Updated 10:10 AM CDT, Mon March 28, 2022
JACKSONVILLE, Fla. – RedDress began shipments of 400 of its ActiGraft systems to multiple hospitals in Ukraine the week of March 21. In addition to donating the FDA-cleared blood clotting wound care systems, the company is coordinating with its partner medical specialists from GraftIn and SlavaMed to help with delivery into Ukraine, and with another partner, Dr. Arkadiy Savchenko of Danylo Halytsky Lviv National Medical University, to teach nurses, doctors and aid workers in the country on how to use the systems. “We’re grateful we’re in a position to not only have cutting-edge product that has a far greater success rate than traditional wound care treatment options, but also that we have the ability to be financially capable to donate these resources to help so many people in need,” said Robert Mueller, general manager of RedDress. ActiGraf is a new, propriety and patented technology solution used to help with wound care that enables health care providers to produce – in real time – in vitro blood clots from a patient’s whole blood. Once applied, the blood clot supports wound management and naturally occurring processes in the patient’s body. RedDress is a privately held, Israel-based company with a U.S. subsidiary, RedDress Ltd. In Ponte Vedra Beach, Fla.
Comments